News
Head and neck cancer is a broad term for several types of cancers that include the mouth (oral cavity), throat (pharynx), voice box (larynx), sinuses and nose cavity, and salivary glands. Head and ...
This guide for newly diagnosed patients provides key information to help you understand your options and have informed ...
NEW YORK -- Screening is the critical first line of defense in early detection of Head and Neck cancer. Dr. Tom Thomas, medical director of head and neck reconstructive and transoral robotic surgery ...
Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain head and neck cancers from returning. Continuous use of Keytruda—both ...
Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...
As cannabis use continues to increase in the U.S., researchers from The University of Oklahoma are investigating whether it ...
Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for ...
What Are the Different Types of Oral Cancer Surgery? Oral cancer surgery refers to a group of procedures with different jobs: removing cancer, rebuilding areas affected by treatment, or restoring key ...
Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable locally advanced head and neck cancer. But the breakthrough approval comes ...
16don MSN
How Fear of Scars in Head and Neck Cancers Delays Treatment – And What Doctors Are Doing About It
This is where Robot assisted surgery has transformed the landscape of head and neck cancer treatment. Unlike conventional ...
Keytruda reduced the risk of recurrence, progression, or death by 30% vs. standard of care in HNSCC patients. Median event-free survival was 59.7 months with Keytruda vs. 29.6 months with standard ...
A new analysis finds that nearly half of head and neck cancer trials go unpublished, particularly those that lack ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results